Victoria Atkinson Clinical Oncology Society of Australia Annual Scientific Meeting 2021

Abstracts this author is presenting:

• EORTC 1325-MG/KEYNOTE-054 phase 3 trial of pembrolizumab versus placebo for completely resected high-risk stage III melanoma: pembrolizumab crossover and rechallenge following recurrence — e-Poster Listing